BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19859937)

  • 1. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data.
    Shmueli K; de Zwart JA; van Gelderen P; Li TQ; Dodd SJ; Duyn JH
    Magn Reson Med; 2009 Dec; 62(6):1510-22. PubMed ID: 19859937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.
    Yao B; Li TQ; Gelderen Pv; Shmueli K; de Zwart JA; Duyn JH
    Neuroimage; 2009 Feb; 44(4):1259-66. PubMed ID: 19027861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition.
    Li W; Wu B; Liu C
    Neuroimage; 2011 Apr; 55(4):1645-56. PubMed ID: 21224002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
    Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
    Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods.
    Wharton S; Bowtell R
    Neuroimage; 2010 Nov; 53(2):515-25. PubMed ID: 20615474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility mapping in the human brain using threshold-based k-space division.
    Wharton S; Schäfer A; Bowtell R
    Magn Reson Med; 2010 May; 63(5):1292-304. PubMed ID: 20432300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility weighted imaging with multiple echoes.
    Denk C; Rauscher A
    J Magn Reson Imaging; 2010 Jan; 31(1):185-91. PubMed ID: 20027586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping.
    Li J; Chang S; Liu T; Wang Q; Cui D; Chen X; Jin M; Wang B; Pei M; Wisnieff C; Spincemaille P; Zhang M; Wang Y
    Magn Reson Med; 2012 Nov; 68(5):1563-9. PubMed ID: 22851199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
    Betts MJ; Acosta-Cabronero J; Cardenas-Blanco A; Nestor PJ; Düzel E
    Neuroimage; 2016 Sep; 138():43-63. PubMed ID: 27181761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility gradient quantization by MRI signal response mapping (SIRMA) to dephaser.
    Franconi F; Chapon C; Le Jeune JJ; Richomme P; Lemaire L
    Med Phys; 2010 Feb; 37(2):877-84. PubMed ID: 20229897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced positive-contrast visualization of paramagnetic contrast agents using phase images.
    Mills PH; Ahrens ET
    Magn Reson Med; 2009 Nov; 62(5):1349-55. PubMed ID: 19780169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the origin of the MR image phase contrast: an in vivo MR microscopy study of the rat brain at 14.1 T.
    Marques JP; Maddage R; Mlynarik V; Gruetter R
    Neuroimage; 2009 Jun; 46(2):345-52. PubMed ID: 19254768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter.
    Walsh AJ; Wilman AH
    Neuroimage; 2011 Jul; 57(2):452-61. PubMed ID: 21513807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive numerical analysis of background phase correction with V-SHARP.
    Özbay PS; Deistung A; Feng X; Nanz D; Reichenbach JR; Schweser F
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27259117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
    Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
    J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM).
    Schweser F; Deistung A; Reichenbach JR
    Z Med Phys; 2016 Mar; 26(1):6-34. PubMed ID: 26702760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?
    Schweser F; Deistung A; Lehr BW; Reichenbach JR
    Neuroimage; 2011 Feb; 54(4):2789-807. PubMed ID: 21040794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping.
    Schäfer A; Forstmann BU; Neumann J; Wharton S; Mietke A; Bowtell R; Turner R
    Hum Brain Mapp; 2012 Dec; 33(12):2831-42. PubMed ID: 21932259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI.
    Liu T; Spincemaille P; de Rochefort L; Kressler B; Wang Y
    Magn Reson Med; 2009 Jan; 61(1):196-204. PubMed ID: 19097205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Susceptibility Mapping: Concepts and Applications.
    Reichenbach JR; Schweser F; Serres B; Deistung A
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():225-30. PubMed ID: 26198880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.